Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.

about

Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.

Item

http://www.wikidata.org/entity/Q47251151

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Maternal and Fetal Outcomes of ...... cal Hemolytic Uremic Syndrome.

@en

Maternal and Fetal Outcomes of ...... cal Hemolytic Uremic Syndrome.

@nl

type

Item

label

Maternal and Fetal Outcomes of ...... cal Hemolytic Uremic Syndrome.

@en

Maternal and Fetal Outcomes of ...... cal Hemolytic Uremic Syndrome.

@nl

prefLabel

Maternal and Fetal Outcomes of ...... cal Hemolytic Uremic Syndrome.

@en

Maternal and Fetal Outcomes of ...... cal Hemolytic Uremic Syndrome.

@nl

P1476

Maternal and Fetal Outcomes of ...... ical Hemolytic Uremic Syndrome

@en

P2093

Alice Schmidt

http://www.w3.org/2001/XMLSchema#string

Gere Sunder-Plassmann

http://www.w3.org/2001/XMLSchema#string

Maarten Knechtelsdorfer

http://www.w3.org/2001/XMLSchema#string

Natalja Haninger

http://www.w3.org/2001/XMLSchema#string

Raute Sunder-Plassmann

http://www.w3.org/2001/XMLSchema#string

Ágnes Szilágyi

http://www.w3.org/2001/XMLSchema#string

P2860

Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome.

Imitators of severe preeclampsia.

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.

P304

1020-1029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2016090995

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29282226

http://www.w3.org/2001/XMLSchema#string

P921

7bèla

P932

5827586

http://www.w3.org/2001/XMLSchema#string